Timetable 

Satellite Symposium:
New Oral Anticoagulants in Real Practice
Sponsored by Boehringer Ingelheim

Chairpersons: Pierre Amarenco, France 
                     Natan Bornstein, Israel

1. Evidenced-based use of New Oral Anticoagulants and beyond one year experience in Canada Stuart Connolly, Canada 
2. New Oral Anticoagulants in real practice Patrick Mismetti, France
3. New Oral Anticoagulants in cardiology practice: patient cases 
Jean-Yves Le Heuzey, France
4. New Oral Anticoagulants in neurology practice: patient cases 
Jean-Louis Mas, France

Plenary I: Stroke and the Heart
Atrial Fibrillation: Prevention of Stroke and Systemic Embolism
supported by an unrestricted educational grant from Daiichi Sankyo Europe GmbH 

Chairpersons: Louis R. Caplan, USA *
                     Bernard Belhassen, Israel **

1. Epidemiology and Co-Morbidities of AF Elaine M. Hylek, USA **
2. Risk Stratification in Patients with AF Jonas Oldgren, Sweden **
3. New Oral Anticoagulants vs. Vitamin K Antagonist Stuart Connolly, Canada **
4. Update on the Newly Released ACCP Guidelines for Antithrombotic Therapy in AF
Daniel E. Singer, USA ** 

5. Antithrombotic Treatment in Patients not Eligible for OAC
Daniel E. Singer, USA ** 
6. Antiarrhythmic Drugs and Device Management, Rhythm vs. Rate Control
Jean-Yves Le Heuzey, France **
7. Indications and Results of AF Ablation Bernard Belhassen, Israel **
8. Role of LAA Occluder Devices Horst Sievert, Germany **

Satellite Symposium
Stroke Prevention in Atrial Fibrillation: Advances in Oral Anticoagulation
Sponsored by Bayer Healthcare

Chairpersons: Natan Bornstein, Israel 
                      Jean-Yves Le Heuzey, France

1. The Burden of Atrial Fibrillation-Related Stroke: Risk Stratification, Impact on Practice and Heathcare Systems Didier Leys, France
2. Stroke Prevention in Atrial Fibrillation: New Approaches K. Fox, UK
3. Secondary Prevention of Strok in Atrial Fibrillation Pierre Amarenco, France
4. Panel Discussion: Practical Implications

Plenary III: Stroke and the Heart: Cardiac Ischemia and Stroke

Chairpersons: Shinichiro Uchiyama, Japan *
                      Laurent Fauchier, France **

1. Prevalence of CAD in Stroke Patients Pierre Amarenco, France *
2. Detection: Coronaro-Angiography vs. Coro-CT vs. Myocardial Scintigraphy
Antti Saraste, Finland ** 
3. Predicting CAD in Stroke Patients (IMT, Carotid Plaques, CAC)
Natan Bornstein, Israel *
4. IHD as a Source of Embolism (LV Thrombus, LV Aneurysm): Management
Veronique Roger, USA **

Plenary IV: Stroke of Unknown Cause and the Heart

Chairpersons: Milija Mijajlovic, Serbia *
                     Genevieve Derumeaux, France **

1.Definition and Prevalence of a Stroke of Unknown Cause: How Far to Explore After a Stroke or TIA with No Obvious Cause Ralph L. Sacco, USA *
2. Yield of New Devices to Detect an Arrythmia (holter Monitoring, Transtelephonic ECG, Implantable Devices Raphael Rosso, Israel **
3. Septal Abnormalities
How to Detect Them, PFO and Stroke Risk Genevieve Derumeaux, France **
To Close, no Jean-Louis Mas, France *
To Close, yes Heinrich Mattle, Switzerland *

Satellite Symposium:
Stroke Prevention in Atrial Fibrillation: Guidelines, Patients and Debates
Sponsored by Bristol-Myers Squibb/Pfizer 

Chairperson: Pierre Amarenco, France

1. ESC Guidelines in everyday clinical practice? Lars Hvilsted Rasmussen, Denmark
2. Which patients should be treated with vitamin K antagonists?
Jean-Philippe Collet, France
3. The aspirin debate: cardiologist and neurologist perspectives Didier Leys, France
4. Panel Discussion

Plenary VI: Vascular Neurology for the Cardiologist: Handling the Acute Phase of Stroke

Chairpersons: Philippe Gabriel Steg, France **                     
                     Cathy Sila, USA *

1. Update on IV-Thrombolysis in Patients with an Acute Stroke
Nils Wahlgren, Sweden *
2. Update on Emergent Endovascular Therapy in Patients with Acute Stroke
Mikael Mazighi, France *
3. Why Vascular Neurologists Do Not Like Heparin at the Acute Phase of Stroke?
Peter Sandercock, UK *
4. How to Handle Troponin and ECG after a Stroke Matthias Endres, Germany *
5. Why the Management of an Acute Stroke is Complicated Enough to make Stroke Units Mandatory Peter Langhorne, UK *

Scientific Collaboration Educational Plenary Session
organised by the Society for the Study of Neuroprotection and Neuroplasticity (SSNN)

 Chairpersons: Dafin Muresanu, Romania
                      Natan Bornstein, Israel   

1. The Vascular Contribution in Neurocognitive Disorders Dafin Muresanu, Romania
2. Statins and Stroke Prevention Pierre Amarenco, France
3. Combined Effect of Hypertension and Hyperlipidemia Laszlo Csiba, Hungary

Plenary VII: Vascular Neurology for the Cardiologist: Diagnosis and Prevention

Chairpersons:  Martial Hamon, France **
                       TBA

1. How to Diagnose a Brain Ischemia (Clinic, Biomarkers, CT/MRI)
Bo Norrving, Sweden *
2. Update on the Management of TIAs Francisco Purroy Garcia, Spain *
3. Update on the Management of Carotid Stenosis (CEA vs. Stenting)
Martin Brown, UK *
4. How to Manage Hemorrhagic Strokes (including iatrogenic)
Thorsten Steiner, Germany *
5. What are Carotid or Vertebral Artery Dissections and their Managements?
Didier Leys, France *
6. How Different is the Diagnosis, Prognosis, Evolution and Management of a “Lacunar Stroke” Bo Norrving, Sweden *

Plenary VIII: Between the Heart and the Brain

Chairpersons: Laszlo Csiba, Hungary *
                     Serge Kownator, France **

1. Aortic Arch: How to Detect it, Prevalence, Risk and Management
Ariel Cohen, France **
2. The Use of Ultrasound to Detect Coexisting Extra- and Intracranial Atherosclerotic Lesions Michael G. Hennerici, Germany *
3. Aortic Dissection: Stroke in the Context of Aortic Dissection, Diagnostic and Therapeutic Management Christoph Nienaber, Germany **